The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 35 results:
Author Title Type [ Year(Asc)]
Filters: Author is Apostolidis, Apostolos  [Clear All Filters]
2021
Dimitriadis, F., Papaioannou M., Sokolakis I., Fragou A., Hatzichristou D., & Apostolidis A. (2021).  The Effect of Low Intensity Extracorporeal Shockwave Treatment on the Urinary Bladder of an Experimental Diabetic Rat Model.. Int Neurourol J.
2020
Smith, P. P., Valentini F., Mytilekas K-V., Apostolidis A., Rademakers K., Cardozo L., et al. (2020).  Can we improve our diagnosis of impaired detrusor contractility in women? An ICI-RS 2019 proposal.. Neurourol Urodyn. 39 Suppl 3, S43-S49.
Boutziona, I., Papanikolaou D., Sokolakis I., Mytilekas K. Vaios, & Apostolidis A. (2020).  Healthcare Access, Quality, and Satisfaction Among Albanian Immigrants Using the Emergency Department in Northern Greece.. J Immigr Minor Health. 22(3), 512-525.
Apostolidis, A., Papaefstathiou E., & Gatsos S. (2020).  Intravesical Botox for overactive bladder; how to minimize complications and manage failures.. Curr Drug Targets.
Apostolidis, A., Papaefstathiou E., & Gatsos S. (2020).  Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage Failures. Current Drug Targets. 21(15), 1527 - 1536.
Apostolidis, A., & Cameron A. P. (2020).  Neurourological Management After Failed Intradetrusor OnabotulinumtoxinA Injections.. Eur Urol Focus. 6(5), 814-816.
Tarcan, T., Selai C., Herve F., Vrijens D., Smith P. P., Apostolidis A., et al. (2020).  Should we routinely assess psychological morbidities in idiopathic lower urinary tract dysfunction: ICI-RS 2019?. Neurourol Urodyn. 39 Suppl 3, S70-S79.
2019
von Gontard, A., Vrijens D., Selai C., Mosiello G., Panicker J., van Koeveringe G., et al. (2019).  Are psychological comorbidities important in the aetiology of lower urinary tract dysfunction-ICI-RS 2018?. Neurourol Urodyn. 38 Suppl 5, S8-S17.
Tarcan, T., von Gontard A., Apostolidis A., Mosiello G., & Abrams P. (2019).  Can we improve our management of dysfunctional voiding in children and adults: International Consultation on Incontinence Research Society; ICI-RS2018?. Neurourol Urodyn. 38 Suppl 5, S82-S89.
Chermansky, C., Mitsogiannis I., Abrams P., & Apostolidis A. (2019).  Stem cells and lower urinary tract dysfunction: Has its potential finally reached clinical maturity? ICI-RS2018.. Neurourol Urodyn. 38 Suppl 5, S134-S141.
Apostolidis, A. (2019).  Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction?. World J Urol. 37(12), 2811-2812.
2018
Abrams, P., Andersson K-E., Apostolidis A., Birder L., Bliss D., Brubaker L., et al. (2018).  6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE.. Neurourol Urodyn. 37(7), 2271-2272.
Sakalis, V., Sfiggas V., Vouros I., Salpiggidis G., Papathanasiou A., & Apostolidis A. (2018).  Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study.. Int J Urol. 25(8), 737-745.
Rahnama'i, M. S., Marcelissen T., Apostolidis A., Veit-Rubin N., Schurch B., Cardozo L., et al. (2018).  The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol.. Neurourol Urodyn. 37(S4), S99-S107.
Cotterill, N., Madersbacher H., Wyndaele J. J., Apostolidis A., Drake M. J., Gajewski J., et al. (2018).  Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013.. Neurourol Urodyn. 37(1), 46-53.
Sakalis, V. I., Sfiggas V., Vouros I., Salpiggidis G., Papathanasiou A., & Apostolidis A. (2018).  Subtle errors of bladder wall thickness measurement have a significant impact on the calculation of ultrasound-estimated bladder weight. A pilot study.. Med Ultrason. 20(3), 292-297.
Apostolidis, A., Wagg A., A'i M. S. Rahnam, Panicker J. N., Vrijens D., & von Gontard A. (2018).  Is there "brain OAB" and how can we recognize it? International Consultation on Incontinence-Research Society (ICI-RS) 2017.. Neurourol Urodyn. 37(S4), S38-S45.
2017
Apostolidis, A., Averbeck M. Augusto, Sahai A., Rahnama'i M. Sajjad, Anding R., Robinson D., et al. (2017).  Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015).. Neurourol Urodyn. 36(4), 882-893.
Apostolidis, A. (2017).  Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?. BJU Int. 120(4), 459-460.
Rantell, A., Apostolidis A., Anding R., Kirschner-Hermanns R., & Cardozo L. (2017).  How does lower urinary tract dysfunction affect sexual function in men and women? ICI-RS 2015-Part 1.. Neurourol Urodyn. 36(4), 949-952.
Apostolidis, A., Rantell A., Anding R., Kirschner-Hermanns R., & Cardozo L. (2017).  How does lower urinary tract dysfunction (LUTD) affect sexual function in men and women? ICI-RS 2015-Part 2.. Neurourol Urodyn. 36(4), 869-875.
Georgopoulos, P., & Apostolidis A. (2017).  Neurogenic voiding dysfunction.. Curr Opin Urol. 27(3), 300-306.
Drake, M. J., Morris N., Apostolidis A., Rahnama'i M. S., & Marchesi J. R. (2017).  The urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 2015.. Neurourol Urodyn. 36(4), 850-853.
2016
Apostolidis, A., Rahnama'i M. S., Fry C., Dmochowski R., & Sahai A. (2016).  Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.. Neurourol Urodyn. 35(2), 293-8.
Drake, M. John, Apostolidis A., Cocci A., Emmanuel A., Gajewski J. B., Harrison S. C. W., et al. (2016).  Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013.. Neurourol Urodyn. 35(6), 657-65.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.